Evidence map›Paper›PMID 14500472›Full record

ArticleInfection and immunity2003

Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.

Seung Hyun Han, Je Hak Kim, Michael Martin, Suzanne M Michalek, Moon H Nahm

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 184 citations in OpenAlex.

  1. Optimization of the Purification Process forJournal of microbiology and biotechnology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Anti-Inflammatory Efficacy of Human-DerivedJournal of microbiology and biotechnology · 2023
    Article
  7. Lipoteichoic acid ofFrontiers in immunology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in microbiology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Seung Hyun HanDepartment of Pathology, University of Alabama at Birmingham, 845 19th Street South, BBRB 614, Birmingham, AL 35294, USA.
Je Hak Kim
Michael Martin
Suzanne M Michalek
Moon H Nahm
University of Alabama at Birmingham · US

Funding

Genetically Engineered Oral Vaccines &Caries ImmunityR01DE009081 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 1990 to 2012
$3.2M
Mechanisms of Immune Modulation and Periodontal DiseaseR01DE014215 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATZ, JANNET · 2001 to 2011
$2.8M
Impact of a new group 6 serotype on pneumococcal vaccinesR01AI031473 · NIAID · WASHINGTON UNIVERSITY · PI NAHM, MOON H. · 1991 to 2011
$1.7M
Pneumococcal capsule and host innate immunityR56AI031473 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAHM, MOON H. · 2012 to 2012
$366k
Mechanisms of Immune Modulation and Periodontal DiseaseR56DE014215 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATZ, JANNET · 2007 to 2007
$364k
NIAID NIH HHS AI 31473NIAID NIH HHS R01 AI031473NIAID NIH HHS R56 AI031473NIDCR NIH HHS DE 09081NIDCR NIH HHS DE 14215NIDCR NIH HHS R01 DE009081NIDCR NIH HHS R01 DE014215NIDCR NIH HHS R56 DE014215
6 · The paper itself

Abstract

Streptococcus pneumoniae is a leading cause of gram-positive sepsis, and lipoteichoic acid (LTA) may be important in causing gram-positive bacterial septic shock. Even though pneumococcal LTA is structurally distinct from the LTA of other gram-positive bacteria, the immunological properties of pneumococcal LTA have not been well characterized. We have investigated the ability of LTAs to stimulate human monocytes by using highly pure and structurally intact preparations of pneumococcal LTA and its two structural variants. The variants were pneumococcal LTA with only one acyl chain (LTA-1) and completely deacylated LTA (LTA-0). The target cells used in the study were peripheral blood mononuclear cells (PBMCs) and two model cell lines (CHO/CD14/TLR2 and CHO/CD14/TLR4) that express human CD25 protein in response to Toll-like receptor 2 (TLR2) and TLR4 stimulation, respectively. Intact pneumococcal LTA and LTA-1 stimulated PBMC and CHO/CD14/TLR2 cells in a dose-dependent manner but did not stimulate CHO/CD14/TLR4 cells. Pneumococcal LTA was about 100-fold less potent than Staphylococcus aureus LTA in stimulating the CHO/CD14/TLR2 cells and PBMCs. LTA-0 (or pneumococcal teichoic acid) stimulated neither CHO/CD14/TLR2 nor CHO/CD14/TLR4 cells even at high concentrations. Excess teichoic acid, LTA-0, antibodies to phosphocholine, or antibodies to TLR4 did not inhibit the LTA-induced TLR2 stimulation. However, antibodies to CD14, TLR1, or TLR2 suppressed tumor necrosis factor alpha (TNF-alpha) production by PBMCs in response to LTA or LTA-1. These results suggest that pneumococcal LTA with one or both acyl chains stimulates PBMCs primarily via TLR2 with the help of CD14 and TLR1.

Indexed as

AnimalsCHO CellsCricetinaeHumansIn Vitro TechniquesLeukocytes, MononuclearLipopolysaccharide ReceptorsLipopolysaccharidesMembrane GlycoproteinsNF-kappa BReceptors, Cell SurfaceReceptors, Interleukin-2Species SpecificityStaphylococcus aureusStreptococcus pneumoniaeTeichoic AcidsLipopolysaccharide ReceptorsLipopolysaccharideslipoteichoic acidMembrane GlycoproteinsNF-kappa BReceptors, Cell SurfaceReceptors, Interleukin-2Teichoic AcidsTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 1Toll-Like Receptor 2Toll-Like Receptor 4Toll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID14500472
PMCPMC201083
OpenAlexW2135563180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.